Date:5/1/2008

spinal therapies. The first products will set the standard for preparing the spinal disc for artificial nucleus replacement and minimally invasive fusion devices, becoming the preferred method for effective and safe preparation of the lumbar spinal disc space. For additional information, please visit the company's website at http://www.corespinetech.com or visit booth #327 during the Spine Arthroplasty Society's Annual Meeting.

'/>"/>

SOURCE CoreSpine Technologies, LLC Copyright©2008 PR Newswire. All rights reserved

1 GOOD

Page: 1 2
Related medicine technology :

1. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
2. Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimers Disease
3. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
4. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
5. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
6. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
7. Senesco Technologies Initiates Preclinical Studies for Cancer Target
8. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
9. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
10. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study